Results 101 to 110 of about 18,434 (234)

Beneficial Effect of Luteal-phase Gonadotropin-releasing Hormone Agonist Administration on Implantation Rate Afterintracytoplasmic Sperm Injection

, 2009
SummaryObjectiveTo evaluate the effect of gonadotropin-releasing hormone (GnRH) agonist, administered in the luteal phase, on intracytoplasmic sperm injection (ICSI) outcome.Materials and MethodsOne hundred and eighty women undergoing ovarian stimulation
Tabibnejad Nasim, Maryam, Ayazi Rozbahani, Nasim, Tabibnejad, Ayazi Rozbahani Maryam, Razieh, Dehghani Firouzabadi, Dehghani Firouzabadi Razieh   +5 more
core   +1 more source

Structure and function of sea urchin neuropeptides

, 2010
PhDThe subject of this thesis is the identification and functional characterization of sea urchin neuropeptides. Neuropeptides are important mediators of neural signalling in all known animals with a nervous system, including bilaterians, ctenophorans ...
Rowe, Matthew Lyndon
core  

Effects of loperamide on the human hypothalamo-pituitary-adrenal axis in vivo and in vitro. [PDF]

, 1992
Loperamide, an opiate agonist of high specificity for p-receptors, was recently reported to suppress ACTH and cortisol levels in normal subjects, but not in patients with proven ACTH-dependent Cushing’s disease. However, there is little information on
Pfeiffer, M., Lange, M., Auernhammer, Christoph J., Stalla, G.K., Müller, O.A.   +4 more
core   +1 more source

Adjuvant therapy in premenopausal women with hormone-dependent breast cancer

Медицинский совет, 2018
In recent years, several studies have indicated that aromatase inhibitors (AIS) combined with a gonadotropin-releasing hormone agonist (GnRH agonist) are safe and effective in premenopausal patients with hormone receptor positive (HR+) breast cancer (BCA)
V. F. Semiglazov, V. Yu. Lifanova, V. S. Appolonova   +2 more
doaj   +1 more source

Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy

, 2018
Chemotherapy with a gonadotropin-releasing hormone (GnRH) agonist has been reported to protect against ovarian failure. This retrospective, individual matching study from 5 large institutes in Korea found that disease-free survival and distant metastasis-
Moo Hyun Lee, Seonok Kim, Im, Seock Ah, Jun Ho Lee, Kim, Seung Il, Lee, Keun Seok, Ahn, Sei Hyun, Keun Seok Lee, Seung Il Kim, Wonshik Han, Kang, Yong Joon, Jeong Eon Lee, Eun Sook Lee, Yong Joon Kang, Sei Hyun Ahn, Kim, Hee Jeong, Park, Seho, Lee, Eun Sook, Joohyuk Sohn, Han, Wonshik, Lee, Jun Ho, Lee, Jeong Eon, Seho Park, Shin, Hae Na, Hae Na Shin, Kim, Seonok, Seok Jin Nam, Nam, Seok Jin, Seock Ah Im, Lee, Moo Hyun, Sohn, Joohyuk, Hee Jeong Kim   +31 more
core   +1 more source

Efficacy and safety of gonadotropin-releasing hormone agonists used in the treatment of prostate cancer

Drug, Healthcare and Patient Safety, 2011
Seungtaek Choi, Andrew K LeeDepartment of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USAAbstract: Androgen deprivation therapy (ADT) is the most effective systemic treatment for prostate cancer.
Choi S, Lee AK
doaj  

Use of the gonadotropin-releasing hormone agonist triptorelin in the diagnosis of delayed puberty in boys

, 1995
To differentiate gonadotropin deficiency from delayed puberty in teenage boys, 0.1 mg/m2 of triptorelin, a gonadotropin-releasing hormone agonist, was administered subcutaneously at 4 AM.
TATO', Luciano, ZAMBONI, Giorgio, ANTONIAZZI, Franco   +2 more
core  

Comparison of Machine Learning Models for Long-Term Recurrence of Endometriosis Treated by Laparoscopy Combined With GnRHa

Clinical and Experimental Obstetrics & Gynecology
Background: To construct and compare the predictive efficacy of the random forest (RF) model and gradient boosting machine (GBM) model for long-term recurrence of endometriosis (EMs) treated by laparoscopy combined with gonadotropin ...
Ke Zhou, Rong Zhu, Yue Jin
doaj   +1 more source

Central precocious puberty and gonadotropin releasing hormone agonist treatment [PDF]

, 1996
In order to understand the processes occurring during precocious puberty, one needs to specify what is currently known about normal pubertal development.
Oostdijk, W. (Wilma)
core  

Supplementary Figure 1 from Effects of Oral Contraceptives or a Gonadotropin-Releasing Hormone Agonist on Ovarian Carcinogenesis in Genetically Engineered Mice

, 2009
Supplementary Figure 1 from Effects of Oral Contraceptives or a Gonadotropin-Releasing Hormone Agonist on Ovarian Carcinogenesis in Genetically Engineered ...
Keeley L. Mui (15095043), Helen H. Kim (15095049), Ilyssa O. Gordon (8915402), Ernst Lengyel (614768), Iris L. Romero (15017355), Woo Seok Lee (4723014), Daniela M. Dinulescu (6688526), Thomas N. Krausz (15095046), Sujatha Jagadeeswaran (766106), Melissa L. Gilliam (15095052)   +9 more
core   +1 more source